JP2007518424A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518424A5
JP2007518424A5 JP2006551422A JP2006551422A JP2007518424A5 JP 2007518424 A5 JP2007518424 A5 JP 2007518424A5 JP 2006551422 A JP2006551422 A JP 2006551422A JP 2006551422 A JP2006551422 A JP 2006551422A JP 2007518424 A5 JP2007518424 A5 JP 2007518424A5
Authority
JP
Japan
Prior art keywords
nucleotide
buffer
nucleotide triphosphate
replacing
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006551422A
Other languages
English (en)
Japanese (ja)
Other versions
JP4866248B2 (ja
JP2007518424A (ja
JP2007518424A6 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002414 external-priority patent/WO2005070027A2/en
Publication of JP2007518424A publication Critical patent/JP2007518424A/ja
Publication of JP2007518424A6 publication Critical patent/JP2007518424A6/ja
Publication of JP2007518424A5 publication Critical patent/JP2007518424A5/ja
Application granted granted Critical
Publication of JP4866248B2 publication Critical patent/JP4866248B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006551422A 2004-01-23 2005-01-21 核酸増幅性能改良のための新規ヌクレオチド混合物 Expired - Fee Related JP4866248B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US53881404P 2004-01-23 2004-01-23
US53881604P 2004-01-23 2004-01-23
US53881504P 2004-01-23 2004-01-23
US60/538,815 2004-01-23
US60/538,814 2004-01-23
US60/538,816 2004-01-23
PCT/US2005/002414 WO2005070027A2 (en) 2004-01-23 2005-01-21 A novel nucleotide mixture for improved nucleic acid amplification performance

Publications (4)

Publication Number Publication Date
JP2007518424A JP2007518424A (ja) 2007-07-12
JP2007518424A6 JP2007518424A6 (ja) 2007-10-11
JP2007518424A5 true JP2007518424A5 (https=) 2008-03-06
JP4866248B2 JP4866248B2 (ja) 2012-02-01

Family

ID=34812082

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006551423A Pending JP2007518425A (ja) 2004-01-23 2005-01-21 Hcv3’非翻訳領域を効率的に増幅および検出するためのプライマーおよびプローブの設計
JP2006551422A Expired - Fee Related JP4866248B2 (ja) 2004-01-23 2005-01-21 核酸増幅性能改良のための新規ヌクレオチド混合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006551423A Pending JP2007518425A (ja) 2004-01-23 2005-01-21 Hcv3’非翻訳領域を効率的に増幅および検出するためのプライマーおよびプローブの設計

Country Status (6)

Country Link
US (3) US7364854B2 (https=)
EP (3) EP2042612B1 (https=)
JP (2) JP2007518425A (https=)
AT (3) ATE491810T1 (https=)
DE (3) DE602005023586D1 (https=)
WO (2) WO2005070027A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147118A4 (en) * 2007-04-27 2010-09-01 Eragen Biosciences Inc MATERIALS AND METHOD FOR DETECTING HEPATITIS C VIRUS
US8435741B2 (en) 2007-07-26 2013-05-07 Fujifilm Corporation Isothermal nucleic acid amplification method using surfactant
US20090162856A1 (en) * 2007-11-06 2009-06-25 Hayato Miyoshi Rna detection method
RU2011132045A (ru) * 2008-12-31 2013-02-10 Эбботт Лэборетриз Праймеры и зонды для детектирования вируса гепатита с

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107970A (ja) * 1995-10-17 1997-04-28 Soyaku Gijutsu Kenkyusho:Kk C型肝炎ウイルス由来核酸、該核酸を用いたウイルスの検出方法
EP0052296B1 (en) * 1980-11-12 1984-06-27 Mitsubishi Kasei Corporation Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives
US5087565A (en) * 1984-07-02 1992-02-11 Du Pont Merck Pharmaceutical Company Synthetic process for preparation of 32 P-labeled nucleotides
DE3689223T2 (de) 1985-05-15 1994-03-03 Amoco Corp Cytidinanaloga.
US4876187A (en) 1985-12-05 1989-10-24 Meiogenics, Inc. Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
WO1989001050A1 (en) 1987-07-31 1989-02-09 The Board Of Trustees Of The Leland Stanford Junior University Selective amplification of target polynucleotide sequences
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5030557A (en) 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
JP2650159B2 (ja) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー 核酸増幅方法
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
EP0578329B1 (en) 1989-09-18 1996-03-13 Canon Kabushiki Kaisha Ink jet recording head and ink jet apparatus having same
DK0515506T3 (da) * 1990-02-16 2000-05-08 Hoffmann La Roche Fremgangsmåde til påvisning af carcinogene humane papillomavirus
KR100249110B1 (ko) 1992-05-06 2000-04-01 다니엘 엘. 캐시앙 핵산 서열 증폭 방법, 이에 이용되는 조성물 및 키트
US5648232A (en) * 1993-01-21 1997-07-15 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological best method and reagents
WO1995024499A1 (en) * 1994-03-10 1995-09-14 Gen-Probe Incorporated Method for suppressing inhibition of enzyme-mediated reactions by ionic detergents
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
DE19612779A1 (de) 1996-03-29 1997-10-02 Boehringer Mannheim Gmbh Verfahren zur spezifischen Vervielfältigung von langen Nukleinsäuren durch PCR
EP2264045B1 (en) * 1996-08-14 2015-10-21 Life Technologies Corporation Stable compositions for nucleic acid amplification and sequencing
DE19647055A1 (de) * 1996-11-14 1998-05-20 Boehringer Mannheim Gmbh Stabilisierte wässrige Nukleosidtriphosphat-Lösungen
EP0975806B1 (en) * 1997-04-03 2006-06-21 Invitrogen Corporation Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr)
ZA989950B (en) 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
JP2002512791A (ja) * 1998-04-27 2002-05-08 リボザイム・ファーマシューティカルズ・インコーポレーテッド C型肝炎ウイルス感染に関連する疾患または状態の酵素的核酸治療
AU4515699A (en) * 1998-06-26 2000-01-17 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
US6638714B1 (en) * 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
WO2000075338A2 (en) * 1999-06-04 2000-12-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF
US6271004B1 (en) 1999-06-25 2001-08-07 Display Systems Biotech A/S Method for improved reverse transcription at high temperatures
EP1233976A4 (en) * 1999-11-17 2003-06-11 Jiuping Ji SIMULTANEOUS DETECTION OF HBV, HCV AND HIV IN PLASMA SAMPLES WITH THE AID OF A MULTIPLEX FIXING TEST
AU2001254670A1 (en) * 2000-03-02 2001-09-12 Akzo Nobel N.V. Detection of hepatitis b virus rna
EP1383782A1 (en) * 2001-03-26 2004-01-28 Sirna Therpeutics, Inc. Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
WO2003016572A1 (en) * 2001-08-17 2003-02-27 Eli Lilly And Company Oligonucleotide therapeutics for treating hepatitis c virus infections
US6783940B2 (en) * 2001-10-31 2004-08-31 Applera Corporation Method of reducing non-specific amplification in PCR
US6750009B2 (en) * 2002-01-29 2004-06-15 Apath, Llc Multiple viral replicon culture systems
WO2003100014A2 (en) * 2002-05-24 2003-12-04 Smithkline Beecham Corporation Method for quantitating negative strand rna synthesis

Similar Documents

Publication Publication Date Title
JP2008245635A5 (https=)
GT200500053S (es) Botella
EG25147A (en) Process for the manufacture of 1,2-dichloroethane.
MEP44608A (en) Methods for treating infectious disease exacerbated asthma
SG10201408300PA (en) Processing of amplified dna fragments for sequencing
SI1935331T1 (sl) Postopek za pripravo modificiranih elektrod, elektrode pripravljene z omenjenim postopkom in encimatski biosenzorji, ki obsegajo omenjene elektrode
EP1899800A4 (en) ETL DIAGRAM AND TOOL FOR STRUCTURED AND UNSTRUCTURED DATA
DK2035398T3 (da) Immobiliseret 1,2-benzisothioazolin-3-on
WO2006135684A3 (en) Methods and kits for sense rna synthesis
EP2071025A4 (en) PRIMER SET FOR THE REINFORCEMENT OF THE UGT1A1 GENE, REAGENT FOR THE REINFORCEMENT OF THE UGT1A1 GENE THEREFOR AND APPLICATION THEREOF
EP1891186A4 (en) HYDROGEN-PRODUCING FUEL-PROCESSING ARRANGEMENTS, HEATING ARRANGEMENTS AND OPERATING METHOD THEREFOR
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
JP2009504138A5 (https=)
EA200701742A1 (ru) Способы получения сиропа
EP2055789A4 (en) PRIMER SET FOR THE REINFORCEMENT OF THE CYP2C19 GENE, REAGENT FOR THE REINFORCEMENT OF THE CYP2C19 GENE THEREFOR AND APPLICATION THEREOF
JP2009520748A5 (https=)
EP2116598A4 (en) Novel Beta GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE, GENE FOR THEIR CODING AND METHOD FOR INCREASING ENZYMATIC ACTIVITY
EP2055775A4 (en) PRIMER ASSEMBLY FOR AMPLIFYING THE CYP2C9 GENE, A REAGENT FOR CYP2C9 GENE AMPLIFICATION, AND USE THEREOF
JP2008542528A5 (https=)
JP2007518424A5 (https=)
EP2029723A4 (en) TFLA-GEN, which may lead to the degradation of toxoflavin and its chemical derivatives, as well as the transgene-expressing transgenic organism
ZA200805382B (en) Keratin-binding effector molecules, and method for the production thereof
EP2055774A4 (en) PRIMER SET FOR THE REINFORCEMENT OF THE SULT1A1 GENE, REAGENT FOR THE REINFORCEMENT OF THE SULT1A1 GENIUS THEREFOR AND APPLICATIONS THEREOF
GB2450454A (en) Terminating substrates for DNA polymerases
WO2010015632A3 (en) Interferon